Vijaypd CeuticalNSE:VIJAYPD -4.05%14 EBITDA Margin % is 8.51% as of Mar. 2025, which is at its 10-year median of 8.51. GuruFocus rates NSE:VIJAYPD with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Vijaypd Ceutical ranks worse than 55.19% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Vijaypd Ceutical's EBITDA for the
six
months ended in Mar. 2025 was ₹91 Mil. Vijaypd Ceutical's Revenue for the
six
months ended in Mar. 2025 was ₹1,068 Mil. Therefore, Vijaypd Ceutical's EBITDA margin for the quarter that ended in Mar. 2025 was 8.51%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Vijaypd Ceutical EBITDA Margin % Related Terms
Vijaypd Ceutical EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Vijaypd Ceutical's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Vijaypd Ceutical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaypd Ceutical EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vijaypd Ceutical's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Vijaypd Ceutical's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vijaypd Ceutical (NSE:VIJAYPD) has a EBITDA Margin % of 8.51% as of Mar. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vijaypd Ceutical and its competitors. This is near median its historical median of 8.51. Over the past decade, Vijaypd Ceutical's EBITDA Margin % has ranged from 6.27 to 8.94. According to the industry distribution chart, Vijaypd Ceutical ranks #367 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 55.2%.
Is Vijaypd Ceutical's EBITDA Margin % too high?
Vijaypd Ceutical's current EBITDA Margin % of 8.51% is near median its 10-year median of 8.51. Over the past 10 years, this metric has ranged from a low of 6.27 to a high of 8.94. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Vijaypd Ceutical's value of 8.51% is 16.9% below this industry median. Based on the distribution chart, Vijaypd Ceutical ranks #367 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Vijaypd Ceutical has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vijaypd Ceutical's EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Vijaypd Ceutical ranks #367 out of 665 companies for EBITDA Margin %. This places Vijaypd Ceutical in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Vijaypd Ceutical's value of 8.51% is 16.9% below this benchmark. Historically, Vijaypd Ceutical's own EBITDA Margin % has ranged from 6.27 to 8.94 over the past decade. While the company's 10-year median is 8.51 vs. the industry median of 10.24, Vijaypd Ceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaypd Ceutical's current EBITDA Margin % of 8.51% is 16.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vijaypd Ceutical and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaypd Ceutical's current EBITDA Margin % is 8.51%, which is near median its own 10-year median of 8.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaypd Ceutical stock overvalued right now?
Vijaypd Ceutical (NSE:VIJAYPD) has a current EBITDA Margin % of 8.51%. The current EBITDA Margin % is 8.51%, which is near median its 10-year median of 8.51 and 16.9% below the Healthcare Providers & Services industry median of 10.24. Vijaypd Ceutical's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Vijaypd Ceutical (NSE:VIJAYPD), the current EBITDA Margin % is 8.51% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vijaypd Ceutical Ltd is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. The company offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits.
14GF Score
Get the complete analysis for NSE:VIJAYPD
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VIJAYPD has been successfully added to your 